Mr Robert J Bell joined the Trust as chief executive in March 2005 from the William Osler Health Centre, Ontario, Canada, where he was president and chief executive officer. He has had over 40 years’ international experience in hospital and health services management. He is a member of the board of directors of Imperial College Health Partners, the Institute of Cardiovascular Medicine and Science and the heart charity CORDA.
Mr Bell has previously held positions as vice president, Health Care and Life Sciences Market Sectors, Cap Gemini, Ernst & Young Canada Inc; partner, Ernst & Young and at KPMG (Peat Marwick), Toronto; vice president, Hilton Universal Hospitals UK Ltd, London; vice president, International Services, Extendicare Inc (London and Toronto); executive director of District Health Councils in the Ministry of Health, Ontario; Treasury Board officer, Management Board of Cabinet, Government of Ontario; and systems engineer, Hospital for Sick Children, Toronto. He is a Bachelor of applied science in industrial engineering and a Master of public administration.
Mr Robert Craig is the Trust's chief operating officer. He joined Harefield Hospital in 1995, having previously worked in community and general hospital services. Following the Trust merger in 1998, he became site director at Harefield and, in 2001, deputy director of operations for the Trust. Robert has also fulfilled the roles of director of governance and quality (2003-2006) and director of planning and strategy (2006-2009) – in the latter post, he was responsible for the Trust’s foundation trust application. He was appointed to his current role in mid-2008.
Professor Timothy Evans BSc MD PhD DSc FRCP FRCA FMedSci is medical director of the Trust and was appointed deputy chief executive on 31 March 2006. In addition to his various roles within the Trust (such as director of clinical governance and consultant in intensive care and thoracic medicine), he is professor of intensive care medicine at Imperial College London, head of the unit of critical care at the National Heart and Lung Institute, and honorary consultant in intensive care medicine to HM Forces. He is also vice dean of the faculty of intensive care medicine and academic vice president of the Royal College of Physicians. Mr Nicholas Hunt
is director of service development for the Trust and also site director at Harefield, a role he took on in 2006. He has worked at Royal Brompton & Harefield NHS Foundation Trust since its inception. Mr Hunt began his career at Regional HQ, the forerunner of Strategic Health Authorities. His subsequent career in NHS management has included both operational and strategic roles at a number of London hospitals.
Mr Richard Paterson
joined the Trust as interim director of finance in January 2011 for a six-month term. He subsequently rejoined the Trust as associate chief executive - finance and was appointed to the Board on 26 October 2011. He worked at KPMG, accountants and business advisers, for 40 years, appointed to the partnership in 1986 and retiring in 2010. In addition to client responsibilities for listed companies and public interest entities, his management roles included: six years in charge of KPMG UK's infrastructure, government and healthcare division; head of markets for KPMG's Europe, Middle East and Africa region; and executive chair of the global professional indemnity insurance committee, a committee of the international board of KPMG. Mr Paterson continues to provide ad hoc consultancy services to KPMG.
Ms Joy Godden, interim director of nursing and clinical governance, was a staff nurse and ward sister for 15 years before she joined the Trust in 1996 as the senior nurse in surgery at Royal Brompton Hospital. Ms Godden worked in this position for six years before undertaking a secondment in a clinical planning role for a year. On completion of the secondment, she was appointed general manager for respiratory medicine and then progressed to become divisional manager for lung services between 2004 and 2015. This role had a broad portfolio that included a number of corporate projects.
Sir Robert Finch was appointed by the Appointments Commission as the Trust’s chairman, effective from 1 January 2009 for a four-year term. His term of office has since been extended by the Trust's Council of Governors. As Sir Robert has now served more than six years, his appointment has become subject to annual reconfirmation by the Council of Governors.
Sir Robert brings significant board experience to the Trust, both in the business and not-for-profit sectors. He has a legal background, having qualified as a solicitor in 1969. He spent his career at the City law firm Linklaters, latterly as a head of real estate. He is a former alderman of the City and former Lord Mayor of London (2003-2004) and has been a member of a number of City Corporation committees. In 2005, Sir Robert joined the board of Liberty International plc, a FTSE 100 London-based property company and held this position until July 2008.
Mrs Lesley-Anne Alexander CBE has been chief executive of the Royal National Institute of Blind People (RNIB) since January 2004, prior to which she was director of operations for the Peabody Trust and director of housing for the London Borough of Enfield. She joined Royal Brompton & Harefield NHS Foundation Trust as a non-executive director in February 2013.
Mrs Alexander currently chairs both the UK Vision Strategy Group and ACEVO (the Association of Chief Executives of Voluntary Organisations). She was awarded a CBE in The Queen's 2012 Birthday Honours list in recognition of her services to the voluntary sector.
Mr Luc Bardin
brings a wealth of experience in leadership and strategic transformation to the Trust. He spent many years in executive roles with BP plc, including group chief sales and marketing officer, CEO of multiple businesses, and CEO and founder of the "Strategic Accounts" division. He was a group vice president for 12 years and a member of the BP Downstream ExCo. His career in global business leadership spans 30 years and, alongside BP, he has worked for Burmah Castrol, Hoechst and Pechiney groups.
Since January 2014, he has been chairman of Strategic Partnering Ltd and is the author of Strategic Partnering - remove chance and deliver consistent success
, published in 2013.
Mr Bardin is an adjunct professor at Imperial College Business School, and has an MBA and qualifications in engineering, political science and finance.
His appointment as non-executive director was approved by the Council of Governors on 1 June 2015.
Mr Philip Dodd
was formally appointed to the Trust Board on 21 July 2014. He has previously been a member of the Council of Governors where he has represented north west London since the very beginning of the Trust’s application to become a foundation trust. While in the role of governor, he was an active fundraiser as well as serving on the Nominations and Remuneration Committee of the Council of Governors. His involvement with Royal Brompton & Harefield NHS Foundation Trust started at Harefield Hospital in 1993 when his son, at eight weeks old, had the first of two successful operations.
Mr Dodd has broad experience in management having held directorships in over 25 companies. He is currently investment director at Semperian PPP Investment Partners.
Mr Richard Jones
joined the Trust Board in February 2014. He is an experienced real estate executive director. He brings to the Board extensive expertise in investment and asset performance and management gained from a long career with Aviva Investors as head of European Life Funds, managing director UK Real Estate and, most recently, managing director of Aviva Clients and Global Asset Management. While in this role he was a member of the Aviva Investors Global Real Estate Board, chair of the Real Estate Operational Management Group and chair of the Real Estate Sustainability Group.
He is currently a member of the Royal Institution of Chartered Surveyors (MRICS) and a non-executive director of the Transport for London Commercial Property Advisory Group.
Mr Neil Lerner was first appointed to the Trust Board in February 2010, with a three-year reappointment approved in February 2013, effective until January 2016. He is an experienced accountant specialising in all aspects of risk management. He has played a key role in the development of ethical standards for the accountancy profession, globally and in the UK. After becoming partner at leading international provider of professional services, KPMG, in 1984, Mr Lerner held a number of senior positions, including head of privatisations, head of corporate finance and head of transaction services business for KPMG UK, and chairman of the KPMG Global Professional Indemnity Insurance Group. He retired from the firm in 2006 and currently holds a number of non-executive posts.
Ms Kate Owen runs a consulting business advising on change and development in organisations. She retired as vice president executive development at BP in 2005 having worked with the company for 24 years. Her 35-year industry career spanned line management, general HR work, training and organisational transformation. Her previous experience was in retail and the public sector. She spent nine years on the board of HM Revenue and Customs, was chair of the Conference Board (Europe) Organisation and Business Council, a member of the Ministry of Defence Armed Forces Training and Education Steering Group and a member of the UK Government Risk Review Steering Group.
Ms Owen is currently a governor of Imperial College, a fellow of the Windsor Leadership Trust and a non-executive director of Bioss International (executive development).
Mr Andrew Vallance-Owen MBE trained as a surgeon in Newcastle upon Tyne but, after holding various positions on the staff of the BMA including head of policy development, became group medical director of Bupa in 1995. Following his retirement from Bupa in 2012, he has taken up a number of non-executive roles; he is chair of the South West Peninsula Academic Health Science Network and the Department of Health’s Patient Reported Outcomes Stakeholder Group. He joined Royal Brompton & Harefield NHS Foundation Trust in February 2013.
He has a strong interest in outcome measurement, clinical audit and greater clinical accountability, and is a passionate advocate of patient feedback in service improvement and shared decision making. Mr Vallance-Owen studied medicine at Birmingham University where he recently received an honorary doctorate.
Non-executive director (non-independent)
Professor Kim Fox is consultant cardiologist at the Trust as well as professor of clinical cardiology and head of the National Heart and Lung Institute, Imperial College, London. Professor Fox is chairman at the Institute for Cardiovascular Medicine and Science (in partnership with Liverpool Heart and chest Hospital) and is the Diana Princess of Wales Chair in Cardiovascular Medicine and Science.
He was appointed as non-executive director (non-independent) to the Trust Board on 1 June 2013.